GET DAILY SIGNALSWhy Is Alamar Biosciences, Inc. (ALMR) Stock Down -8.97% Today?
Key Takeaways
- Shares of ALMR fell roughly 8.97% in intraday trading, giving back most of the prior session's ~11.7% surge.
- Primary catalyst: Profit-taking after a sharp single-day rally, with the stock reversing back below recent technical levels.
- Secondary driver: Continued selling by Qiming Venture Partners affiliates, a pre-IPO holder that has been trimming its stake since the October lock-up expiry.
- Broader context: Elevated volatility in a recently listed, unprofitable proteomics company with a limited trading float.
- What traders are watching next: Third-quarter earnings scheduled for November 3, 2026, and any further insider selling disclosures.
- For additional detail on valuation, estimates, and outlook, explore Price Targets, Earnings, and Forecast pages for ALMR.
- To see which strategies are performing best in the current market, explore Trending AI Robots.
Opening Summary
Alamar Biosciences, Inc. (ALMR), a Fremont, California-based life sciences company that develops precision proteomics platforms for the early detection of disease, pulled back sharply on Thursday. The stock traded around $28.63 intraday, down approximately 8.97% from the prior session's closing price of $31.45. The decline marked a pronounced reversal after shares had rallied more than 11% in the previous session, and it underscores the outsized volatility that has characterized this newly public name since its April 2026 initial public offering.
Profit-Taking After a Sharp Rally
The most immediate catalyst for the decline was a classic round of profit-taking. On the prior trading day, ALMR shares surged more than 11% to close at $31.45, building on renewed buying interest that included reported accumulation by ARK Investment Management. With short-term gains locked in, traders moved to sell into strength on Thursday, driving the stock back toward the upper-$28 range. In a momentum-driven name with a relatively small float, such reversals tend to be amplified as buyers step back and sellers regain control.
Insider Selling Overhang
Compounding the selling pressure is a persistent overhang from large early shareholders. Qiming Venture Partners affiliates, identified as 10% owners of ALMR, have disclosed a series of open-market sales in recent weeks, including transactions reported across October 19–20. The six-month IPO lock-up on the stock expired in mid-October, unlocking a meaningful supply of shares held by pre-IPO investors sitting on significant gains relative to the $17.00 offering price. While insider disposals are common after lock-up expirations, continued Form 4 filings can weigh on sentiment and encourage further distribution among other holders.
Valuation and Volatility Context
The pullback also reflects the demanding valuation assigned to an early-stage, unprofitable company. Alamar has posted strong revenue growth, but it remains loss-making, and its shares have traded in a wide range since going public — from below $19 to a record high near $39.61. With the stock still carrying a premium multiple on a trailing-revenue basis, any shift in risk appetite can trigger outsized moves. Thursday's decline is consistent with a broader pattern of sharp, two-way trading that has defined the stock throughout October.
Market Context and Trading Activity
The move in ALMR appeared to be company-specific rather than a reflection of broad market weakness. The reversal unwound much of the prior session's outsized gain, suggesting concentrated profit-taking in the name rather than a sector-wide rout. From a technical standpoint, the stock slipped back below the prior day's closing level and retreated from the top of its recent trading range, returning toward a zone where it had consolidated in preceding sessions. Traders are closely monitoring whether support holds near the upper-$20s or whether the pullback extends further.
What Comes Next for ALMR
Attention now turns to Alamar's third-quarter earnings report, scheduled for November 3, 2026. Investors will be watching revenue growth, consumables momentum, and any updated guidance, as well as commentary on the company's pathway toward regulatory milestones and new disease-area applications. Additional insider selling disclosures could also influence sentiment in the near term. As an unprofitable, recently public company, ALMR remains sensitive to shifts in risk appetite, and its elevated volatility is likely to persist around key catalysts and liquidity events.
Trending AI Robots
Tickeron offers hundreds of AI-powered trading bots covering thousands of tickers, but only the strongest performers under current market conditions are featured in its curated Trending AI Robots section. These bots vary by strategy, timeframe, performance metrics, and the symbols they trade, allowing users to explore approaches matched to different market environments. For investors seeking a data-driven edge, reviewing the Trending AI Robots page can offer a useful starting point.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
ALMR sees its Stochastic Oscillator climbs out of oversold territory
On October 20, 2026, the Stochastic Oscillator for ALMR moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 4 instances where the indicator left the oversold zone. In 4 of the 4 cases the stock moved higher in the following days. This puts the odds of a move higher at over 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 21, 2026. You may want to consider a long position or call options on ALMR as a result. In 8 of 8 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 90%.
The Moving Average Convergence Divergence (MACD) for ALMR just turned positive on October 21, 2026. Looking at past instances where ALMR's MACD turned positive, the stock continued to rise in 2 of 2 cases over the following month. The odds of a continued upward trend are 90%.
ALMR moved above its 50-day moving average on October 21, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +19.58% 3-day Advance, the price is estimated to grow further. Considering data from situations where ALMR advanced for three days, in 30 of 32 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.
ALMR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The 10-day RSI Indicator for ALMR moved out of overbought territory on October 06, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 5 similar instances where the indicator moved out of overbought territory. In 5 of the 5 cases, the stock moved lower in the following days. This puts the odds of a move lower at 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALMR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.
The Aroon Indicator for ALMR entered a downward trend on September 17, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 11 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.976) is normal, around the industry mean (2.923). P/E Ratio (-43.943) is within average values for comparable stocks, (2.388). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (20.367) is also within normal values, averaging (40.124).
The Tickeron Price Growth Rating for this company is 57 (best 1 - 100 worst), indicating steady price growth. ALMR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 78 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALMR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry MedicalNursingServices
Advertisement